Resultats de la cerca - David Irvine

  • Mostrar 1 - 11 resultats de 11
Refinar resultats
  1. 1
    Targeting hedgehog in hematologic malignancy

    Targeting hedgehog in hematologic malignancy per David Irvine, Mhairi Copland

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database

    Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database per David Gunnell, David Irvine, Lauren A. Wise, Charlotte Aull Davies, Richard M. Martin

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Primary Intraocular Lens Implantation in the Setting of Penetrating Ocular Trauma

    Primary Intraocular Lens Implantation in the Setting of Penetrating Ocular Trauma per Patrick E. Rubsamen, W. David Irvine, Brooks W. McCuen, William E. Smiddy, C. Bradley Bowman

    Publicat 1995
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia

    Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia per David Irvine, Bin Zhang, Ross Kinstrie, Anuradha Tarafdar, Heather Morrison, Victoria Campbell, Hothri A. Moka, YinWei Ho, Colin Nixon, Paul W. Manley, Helen Wheadon, John R. Goodlad, Tessa L. Holyoake, Ravi Bhatia, Mhairi Copland

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy

    CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy per Ross Kinstrie, Gillian A. Horne, Heather Morrison, David Irvine, Chinmay Munje, Eduardo Gómez‐Castañeda, Hothri A. Moka, Karen Dunn, Jennifer E. Cassels, Narissa Parry, Cassie J. Clarke, Mary T. Scott, Richard E. Clark, Tessa L. Holyoake, Helen Wheadon, Mhairi Copland

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma

    Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma per Claire Roddie, Lorna Neill, Wendy Osborne, Sunil Iyengar, Eleni Tholouli, David Irvine, Sridhar Chaganti, Caroline Besley, Adrian Bloor, Ceri Jones, Ben Uttenthal, Rod Johnson, Robin Sanderson, Kathleen Cheok, Maria A. V. Marzolini, William Townsend, Maeve O’Reilly, Amy A. Kirkwood, Andrea Kühnl

    Publicat 2023
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile

    Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile per Kimberly Cramer-Morales, Margaret Nieborowska-Skorska, Kara Scheibner, Michelle R. Padget, David Irvine, Tomasz Śliwiński, Kimberly Haas, Jae Woong Lee, Huimin Geng, Darshan Roy, Artur Słupianek, Feyruz V. Rassool, Mariusz A. Wasik, Wayne E. Childers, Mhairi Copland, Markus Müschen, Curt I. Civin, Tomasz Skórski

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial

    TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial per Kate Cwynarski, Gloria Iacoboni, Eleni Tholouli, Tobias Menne, David Irvine, Nivetha Balasubramaniam, Leigh Wood, Justin Shang, Eric Xue, Yiyun Zhang, Silvia Basilico, Margarida Neves, Meera Raymond, Ian Scott, Mohamed El‐Kholy, Ram Jha, Heather Dainton-Smith, Rehan M. Hussain, William Day, Mathieu Ferrari, Simon Thomas, Koki Lilova, Wolfram Brugger, Teresa Marafioti, Pierre Lao–Sirieix, Paul Maciocia, Martin Pulè

    Publicat 2024
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

    Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia per Claire Roddie, Juliana Dias, Maeve O’Reilly, Mahnaz Abbasian, Amaia Cadiñanos-Garai, Ketki Vispute, Leticia Bosshard‐Carter, Marina Mitsikakou, Vedika Mehra, Harriet Roddy, John A. Hartley, Victoria J. Spanswick, Helen L. Lowe, Bilyana Popova, Laura Clifton‐Hadley, Graham Wheeler, Joanna Olejnik, Adrian Bloor, David Irvine, L. Wood, Maria A. V. Marzolini, Sabine Domning, Farzin Farzaneh, Mark W. Lowdell, David C. Linch, Martin Pulè, Karl S. Peggs

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Dual targeting of CD19 and CD22 with Bicistronic CAR-T cells in Patients with Relapsed/Refractory Large B Cell Lymphoma

    Dual targeting of CD19 and CD22 with Bicistronic CAR-T cells in Patients with Relapsed/Refractory Large B Cell Lymphoma per Claire Roddie, Lazaros J. Lekakis, Maria A. V. Marzolini, Aravind Ramakrishnan, Yiyun Zhang, Yanqing Hu, Vijay Peddareddigari, Nushmia Z. Khokhar, Robert W. Chen, Silvia Basilico, Meera Raymond, Frederick Arce Vargas, Kevin Duffy, Wolfram Brugger, Maeve O’Reilly, Leigh Wood, David C. Linch, Karl S. Peggs, Carlos Bachier, Lihua E. Budde, Connie Lee Batlevi, Nancy L. Bartlett, David Irvine, Eleni Tholouli, Wendy Osborne, Kirit M. Ardeshna, Martin Pulè

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>

    Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i> per Mark J. Levis, Mehdi Hamadani, Brent R. Logan, Richard J. Jones, Anurag K. Singh, Mark R. Litzow, John R. Wingard, Esperanza B. Papadopoulos, Alexander E. Perl, Robert J. Soiffer, Celalettin Üstün, Masumi Ueda, Geoffrey L. Uy, Edmund K. Waller, Sumithra Vasu, Melhem Solh, Asmita Mishra, Lori Muffly, Hee‐Je Kim, Jan‐Henrik Mikesch, Yuho Najima, Masahiro Onozawa, Kirsty Thomson, Arnon Nagler, Andrew H. Wei, Guido Marcucci, Nancy L. Geller, Nahla Hasabou, David Delgado, Matt Rosales, Jason E. Hill, Stanley C. Gill, Rishita Nuthethi, Denise King, Heather Wittsack, Adam Mendizabal, Steven M. Devine, Mary M. Horowitz, Yi‐Bin Chen, Ed Agura, Jessica K. Altman, Αchilles Anagnostopoulos, Sarah Anand, Andrew Artz, Walter E. Aulitzky, Sophia Balderman, Karen K. Ballen, Michael W. Becker, Yves Béguin, Leanne Berkahn, Zwi Berneman, Vijaya Raj Bhatt, Ian Bilmon, Francesca Bonifazi, Adrienne Briggs, Benedetto Bruno, Claudio G. Brunstein, Michael Byrne, Jenny Byrne, Mónica Cabrero, Roberto Cairoli, George Carrum, Jan Černý, Yi‐Bin Chen, June‐Won Cheong, Fabio Ciceri, Mercedes Colorado, Rachel J. Cook, Daniel R. Couriel, Charles Craddock, Lloyd E. Damon, Abhinav Deol, Yohan Desbrosses, Steve Devine, Carmen Di Grazia, Antonio Di Stasi, Ajoy Dias, Kathy Dorritie, James Essell, Tetsuya Eto, Sherif S. Farag, Édouard Forcade, Olga Frankfurt, Shin‐ichiro Fujiwara, Takahiro Fukuda, Kentaro Fukushima, Sabine Fürst, Tatsunori Goto, Aric C. Hall, Shunsuke Hatta, Yosr Hicheri, Mitchell E. Horwitz, Hsin‐An Hou, Jonathan How, Dianna S. Howard, Wei‐Hsun Hsu, Anne Huynh, David Irvine, Takayuki Ishikawa, Katarzyna Jamieson

    Publicat 2024
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: